U.S. markets closed

Co-Diagnostics, Inc. (CODX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
9.83-0.03 (-0.30%)
At close: 4:00PM EDT
9.80 -0.03 (-0.31%)
After hours: 05:53PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Double Moving Average Crossover

Double Moving Average Crossover

Performance Outlook
Previous Close9.86
Open9.97
Bid9.81 x 800
Ask9.94 x 1400
Day's Range9.63 - 10.15
52 Week Range7.01 - 30.99
Volume646,873
Avg. Volume1,088,638
Market Cap283.889M
Beta (5Y Monthly)-1.97
PE Ratio (TTM)5.69
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
32% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Why Co-Diagnostics Blasted 21% Higher on Thursday
    Motley Fool

    Why Co-Diagnostics Blasted 21% Higher on Thursday

    The roller-coaster-like trajectory that has been Co-Diagnostics' (NASDAQ: CODX) stock price climbed another hill on Thursday. Co-Diagnostics announced that its CoPrimer diagnostics platform, which underpins testing products -- like its popular-for-obvious-reasons Logix Smart for COVID-19 -- has been granted a patent in South Korea. "We believe that this patent granted by South Korea provides additional validation of the uniqueness and versatility of the CoPrimer platform," the company quoted CEO Dwight Egan as saying.

  • Co-Diagnostics, Inc. (CODX) Fell Out Of Favor With Hedge Funds
    Insider Monkey

    Co-Diagnostics, Inc. (CODX) Fell Out Of Favor With Hedge Funds

    In this article we will analyze whether Co-Diagnostics, Inc. (NASDAQ:CODX) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There’s no better way to get these firms’ immense resources and analytical capabilities working for us than to follow their lead into […]

  • Earnings Beat: Co-Diagnostics, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
    Simply Wall St.

    Earnings Beat: Co-Diagnostics, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

    It's been a good week for Co-Diagnostics, Inc. ( NASDAQ:CODX ) shareholders, because the company has just released its...